Abstract: An exercise machine with adjustable handles that provide for multiple handle positions. The exercise machine with adjustable handles generally includes a frame with one or more rails, a carriage movably positioned upon the rails, and a pair of adjustable handles positioned near an end of the frame. The adjustable handles each have a handle portion that is movably connected to a corresponding handle stanchion to pivot from a storage position to an extended position.

Abstract: A reversible resistance exercise machine for reversing the direction of applied resistance against a movable platform of an exercising machine. The exercise machine has a frame, a carriage movably positioned upon the frame, and a plurality of biasing members. A plurality of first tension connectors are accessible near the first end of the carriage and are adapted for removably attaching selected biasing members near the first end of the carriage to resist motion of the carriage in the first direction. A plurality of second tension connectors are accessible near the second end of the carriage and are adapted for removably attaching selected biasing members near the second end of the carriage to resist motion of the carriage in the second direction. A user selectable amount of force may be applied to the carriage to resist movement in either of the first direction and the second direction.

Abstract: Provided are long-chain carboxychromanol compounds useful for treating conditions associated with the need to inhibit cyclooxygenase-1, cyclooxygenase-2, and/or 5-lipoxygenase, and pharmaceutical formulations containing the compounds.

Abstract: Described herein are neutral prodrugs of phosphorus-containing inhibitors of farnesyl transferase that include one or more phosphate fragments or analogs of phosphate fragments. Analogs of phosphate fragments include various linkers other than oxygen connecting the phosphate fragment to the remaining portion of the drug, such as but not limited to linkers forming phosphoramidates, phosphonates, difluorophosphonates, phosphordiamidates, and the like.

Abstract: Provided are long-chain carboxychromanol compounds useful for treating conditions associated with the need to inhibit cyclooxygenase-1, cyclooxygenase-2, and/or 5-lipoxygenase, and pharmaceutical formulations containing the compounds.

Abstract: Described herein are neutral prodrugs of phosphorus-containing inhibitors of farnesyl transferase that include one or more phosphate fragments or analogs of phosphate fragments. Analogs of phosphate fragments include various linkers other than oxygen connecting the phosphate fragment to the remaining portion of the drug, such as but not limited to linkers forming phosphoramidates, phosphonates, difluorophosphonates, phosphordiamidates, and the like.

Abstract: The invention provides an odor removal composition characterized by:(a) a complexing agent selected from a biguanide polymer of the formula (1) ##STR1## in which R, R.sup.2, R.sup.2 and R.sup.3 are each a substituted or unsubstituted alkylene group having up to 12 carbon atoms in the main chain, HX is an acid; and n has a value of 2 to 20.(b) a carrier capable of assisting wetting of odor forming compositions; and(c) a cationic moiety; said moiety being part of a chemically independent compound, or chemically associated with a complexing agent or the carrier.

Abstract: The invention provides an odor neutralizing composition comprising:(a) a complexing agent selected from a polymer of the formula (1) ##STR1## in which R is a substituted or unsubstituted alkylene group having up to 12 carbon atoms in the unsubstituted chain.(b) a carrier capable of assisting wetting of odor forming compositions; and(c) a cationic moiety; said moiety being part of a chemically independent compound, or chemically associated with a complexing agent or the carrier.